SCHEMBL24233261

SCHEMBL24233261

CN[C@H](CCCc1ccccc1)C(C)=O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP3 P08254 6/20 0.48
MMP1 P03956 5/20 0.48
MMP9 P14780 1/20 0.48
CYP2D6 P10635 1/20 0.47
CYP2C9 P11712 1/20 0.47
CYP2C19 P33261 1/20 0.47
KMT2A Q03164 1/20 0.47
LMNA P02545 1/20 0.47
PKM P14618 1/20 0.47
HDAC3 O15379 1/20 0.46
MAPK1 P28482 1/20 0.46
ADRA1A P35348 1/20 0.46
HDAC4 P56524 1/20 0.46
SLC6A3 Q01959 1/20 0.46
HDAC1 Q13547 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
HDAC7 Q8WUI4 1/20 0.46
HDAC2 Q92769 1/20 0.46
HDAC10 Q969S8 1/20 0.46
HDAC11 Q96DB2 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25058925 1.00 MMP3 (0.48) MMP3MMP1MMP9CYP2D6CYP2C9
SCHEMBL24233258 1.00 MMP3 (0.48) MMP3MMP1MMP9CYP2D6CYP2C9
SCHEMBL13227756 0.90 TSHR (0.51) KMT2ASMN1; SMN2ALDH1A1HPGDTSHR
SCHEMBL24233257 0.90 TSHR (0.51) KMT2ASMN1; SMN2ALDH1A1HPGDTSHR
SCHEMBL16509240 0.90 TSHR (0.51) KMT2ASMN1; SMN2ALDH1A1HPGDTSHR
SCHEMBL21837706 0.88 GGT1 (0.52) MMP3MMP1CYP2D6CYP2C9CYP2C19
SCHEMBL21837703 0.88 GGT1 (0.52) MMP3MMP1CYP2D6CYP2C9CYP2C19
SCHEMBL23875099 0.85 KDM4E (0.47) LMNASLC6A3ALDH1A1
SCHEMBL16329068 0.85 GNPAT (0.51) MMP3MMP1MMP9CYP2D6CYP2C9
SCHEMBL7997620 0.84 MMP3 (0.52) MMP3MMP1MMP9CYP2D6CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022023723-A1 GLP-1 RECEPTOR ANTAGONISTS HEPTARES THERAPEUTICS LIMITED (GB) 2022-02-03 WO disclosed